For the Inventor, By the Inventor

Enter assignee name

Pierre Fabre S.a.

USPTO Granted Patents = 46

Trademarks = 1

Forward Citations = 425

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Henri Cousse (30 out of 44 patents)

Gilbert Mouzin (28 out of 38 patents)

Gerard Normier (9 out of 14 patents)

4. Antoine Stenger (9 out of 11 patents)

5. Jacques Durand (6 out of 7 patents)

6. Anne-Marie Pinel (5 out of 9 patents)

7. Bernard Bonnaud (5 out of 5 patents)

8. Jean-Pierre Tarayre (4 out of 8 patents)

9. Lucien D D'Hinterland (4 out of 6 patents)

10. Lucien Dussourd d'Hinterland (4 out of 7 patents)

11. Jean-Pierre Rieu (3 out of 14 patents)

12. Silvano Casadio (3 out of 11 patents)

13. Guy Pitet (3 out of 5 patents)

14. M Antoine Stenger (3 out of 3 patents)

15. Andre Delhon (2 out of 6 patents)

Core Competencies:

Topical Formulation

Immunostimulant

Pharmaceutical Compositions

Anxiety Treatment

Vaccine Preparation

Pain Management

Antithrombotic Compounds

Cholesterol Reduction

Psychotropic Properties

Aromatic Keto Acids

Plasminogen Activators

Medicaments

46 patents: Sort by Forward Citations

1. 5030451 - Topical slenderizing formulation containing cafeine carboxylic acid (1991-07-09),

2. 4567288 - 1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) (1986-01-28),

3. 4539413 - Preparation of 3-amino-1-[(1,4-benzodioxan)-2-yl-methoxy]-2-propanols (1985-09-03),

4. 4511566 - 2-N-Cycloalkylmethyl 3-oxo 5,6-diaryl-as-triazines (1985-04-16),

5. 4510142 - Derivatives of biphenyl alkyl carboxylates and their use as medicaments (1985-04-09),

6. 4507318 - 1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) as drugs in the (1985-03-26),

7. 4501693 - Method of preparing immunostimulant proteoglycans which induce (1985-02-26),

8. 4478836 - 1-Aryl 2-aminomethyl cyclopropane carboxyamide (Z) derivatives and their (1984-10-23),

9. 4476061 - 2'-(Orthochlorobenzoyl)-4'-chloroglycylanilides (1984-10-09),

10. 4460575 - Vaccinal complex containing a specific antigen and vaccine containing it (1984-07-17),

11. 4460109 - Device for the distribution of two pasty substances in regulable (1984-07-17),

12. 4456614 - 3-Amino-1-[(1,4-benzodioxan)-2-yl-methoxy]-2-propanols, pharmaceutical (1984-06-26),

13. 4436749 - Compounds of the benzoxepine series and sulphur- and nitrogen-containing (1984-03-13),

14. 4409241 - Method of treating anxiety with (1983-10-11),

15. 4397838 - Preparations of purified bacterial membranal proteoglycans (1983-08-09),

Company Overview

Pierre Fabre S.a. is a prominent French pharmaceutical and dermo-cosmetic company headquartered in Paris. The organization specializes in the development and manufacturing of innovative topical formulations and a range of therapeutic compounds, including immunostimulant and antithrombotic agents. Its research spans various domains, such as vaccine development and psychotropic medicaments, reflecting a commitment to advancing healthcare solutions. Pierre Fabre's expertise in bacterial and proteoglycan technologies positions it as a key player in the global pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

46 Patents

#141 in Paris

#507 in France

#15,110 in the World

Pierre Fabre S.a.

Forward Citations = 425

38 inventors:

Henri Cousse (30 out of 44 patents)

Gilbert Mouzin (28 out of 38 patents)

Gerard Normier (9 out of 14 patents)

4. Antoine Stenger (9 out of 11 patents)

5. Jacques Durand (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pierre Fabre S.a.. Retrieved from https://idiyas.com/company/pierre-fabre-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…